INTRODUCTION
The simultaneous occlusion of two coronary arteries in the setting of ST elevation myocardial Infarction is a rare occurrence and is estimated to occur in 2.5% of all primary PCI patients. 1 Occasionally, such multivessel occlusions of coronary vessels can be at areas where stenting might not be feasible due to very small vessel or very distal vessel occlusion. These lesions pose a unique challenge to the interventional cardiologist. We, herein, report such a case of a patient with simultaneous distal occlusion of two coronary arteries in the setting of ST elevation myocardial infarction that were dealt with intracoronary streptokinase upfront separately in each vessel for restoration of flow, followed by glycoprotein (GP) IIb/IIIa inhibitors infusion and then Factor Xa inhibitor (Rivaroxaban) with full recovery of patient.
CASE REPORT
A 57-year gentleman presented to the Aga Khan University Hospital, Karachi, Pakistan in May 2015 with Killip I Inferoposterior lateral STEMI ( Figure 1A) . ST segments did not show any response to sublingual nitrates in emergency room. His baseline investigations are shown in Table I . He was transferred to the cath lab for emergent coronary angiogram that showed simultaneous occlusion in distal left circumflex artery (LCx) and apical left anterior descending artery (LAD). As the patient had borderline blood pressures, intracoronary nitroglycerin (IC GTN) was not given to rule out spontaneous coronary spasm. Due to the very distal location of the lesions, it was decided to use intracoronary streptokinase (SK) for revascularisation. 250KU intracoronary SK was injected sequentially into the LAD and LCx over 3 minutes via aspiration catheter. Post-intracoronary SK, TIMI III flow was seen both in distal LAD and LCx (Figure 2 ). The ECG changes settled 
DISCUSSION
Review of literature shows that simultaneous occlusion of more than one coronary vessel causing STEMI is unusual and often lethal associated with cardiogenic shock and high mortality. 1,2 Simultaneous occlusion of more than one coronaries may occur due to plaque rupture, embolisation, coronary spasm, hypercoagulable states such as malignancy, thrombocytosis and antithrombin III deficiency. 3, 4 Most of these patients are hemodynamically unstable with high incidence of cardiogenic shock and chances of life-threatening ventricular arrhythmias. 5 A review of literature on the use of thrombolytics in the setting of STEMI with simultaneous multivessel occlusions on coronary angiogram shows four cases which were dealt with intracoronary (IC) thrombolytics (Table II) . In these cases, use of IC thrombolytics was reserved with stenting, mostly for proximal coronary artery lesions. The most common combination for simultaneous occlusions of vessels was LAD and right coronary artery (RCA). Urokinase appeared as the thrombolytic agent of choice. [6] [7] [8] To our knowledge, there is no reported case where an IC thrombolytic therapy with SK was used for distal occlusions in the setting of STEMI caused by simultaneous occlusion of more than one coronary vessels.
Though, IC SK was used in the pre-stenting era, but its use was associated with complications such as systemic Non-stenting approach for distal coronary occlusion bleeding and bleeding at the puncture site. These complications were more pronounced if dose of SK exceeded 200,000 IU. The other major cardiac complications of IC SK administration were reperfusion arrhythmias. With the advent of stenting, the use of IC SK became limited. However, in 2007, Murat in his study used IC SK after stenting in patients undergoing primary percutaneous intervention. 9 The dose used by Murat et al. was 250 KU, at which the chances of SK associated complications were significantly low. However, in that study IC SK was used after stenting to achieve better flow. The authors used this dose of SK (250KU) separately for each vessel upfront without any complications. This case showcases the fact that this dose of SK can be used safely in more than one vessel occlusion.
This case report is an unusual occurrence of STEMI with simultaneous mutlivessel occlusions that might have occurred because of possible simultaneous plaque rupture in multiple coronary arteries or due to embolisation of a proximal clot. In the patient, the TEE did not show any evidence of proximal clot; however, the possibility of clot embolisation from a proximal source cannot be ruled out completely. An intravascular ultrasound (IVUS) might have helped in delineating the etiology. However, due to the distal location of lesions, it was not performed during the angiogram. The history and laboratory workup did not suggest any hypercoagulable state. Another differential was spontaneous coronary spasm in the distal vessels; however, patient did receive sublingual nitrates in emergency room, but due to low blood pressure during the procedure, IC GTN could not be used. Furthermore, we found in our procedure that flow was only restored after fibrinlolytic therapy suggesting a thrombotic event rather than spasm. Other possibility in this case was spontaneous plaque rupture occurring at more than one distinct site simultaneously leading to ST-elevation myocardial infarction. Therefore, to prevent re-occlusion of arteries, we decided to keep our patient initially on GP IIb/IIIa inhibitors and then on Rivaroxaban for few months.
Rivaroxaban, a coagulation Factor Xa inhibitor, is approved for use in nonvalvular atrial fibrillation for the prevention of stroke and systemic embolism. However, in patients with acute coronary syndromes, low-dose Rivaroxaban is known to reduce the risk of the composite end-point of death from cardiovascular causes, myocardial infarction, or stroke. 10 As spontaneous plaque rupture at multiple sites was suspected in our patient, we used a higher dose of Rivaroxaban. This approach helped in our patient's management without recurrence of any clinical events and full recovery of left ventricular function.
This case is unique in which there was simultaneous occlusion of two distal vessels, which were dealt with old (SK, DAPTs and GP IIb/IIIa) inhibitors and new pharmacological agents (Rivaroxaban) combined with percutaneous intervention for full recovery of patient.
Though rare, ST-segment elevation myocardial infarction with simultaneous multiple coronary artery occlusions may occur. In patients with distal coronary lesions not amenable to stenting, the use of IC SK initially and then followed by GP IIb/IIIa inhibitors and newer anticoagulants based on clinical condition and risk factors of patients can provide good immediate angiographic results with full recovery of left ventricular function in these patients on follow-up.
